Main contents starts here

Overview

Takeda is a research-based global pharmaceutical company. As the largest pharmaceutical company in Japan and one of the global leaders of the industry. Setting our management philosophy, “Takeda-ism” as the basis of Business, Takeda is committed to striving towards better health for patients worldwide through leading innovation in medicine.
Takeda is enhancing its R&D pipeline by concentrating its management resources.
Takeda's in-house ethical drugs are marketed in around 90 countries worldwide and are recognized as the brand in major countries worldwide.

General Information

(As of March 31, 2010)
Company Name	Takeda Pharmaceutical Company Limited
Headquarters Head Office	1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645 TEL: +81 6 6204-2111 FAX: +81 6 6204-2880
Tokyo Head Office	12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668 TEL: +81 3 3278-2111 FAX: +81 3 3278-2000
Founded	June 12, 1781
Incorporated	January 29, 1925
President	Yasuchika Hasegawa
Paid-In Capital	¥63.5 billion
Number of Employees	6,566 (parent), 19,654 (consolidated)
Number of Shareholders	236,480
Scope of Business	Manufacturing, marketing and import / export of pharmaceutical drugs, etc.
R&D Facilities	Osaka, Tsukuba (Japan), Palo Alto, San Diego, San Francisco, Deerfield（U.S.）, London, Cambridge（U.K.）, Singapore
Production Facilities	Osaka, Hikari, Italy, Ireland, China, Indonesia
Overseas Subsidiaries and affiliates	U.S., Canada, U.K., France, Italy, Germany, Austria, Switzerland, Spain, Portugal, Ireland, Netherlands, Sweden, Belgium, Turkey, China, Taiwan, Philippines, Thailand, Indonesia, Singapore, Mexico, Brazil

Organization of Takeda Pharmaceutical Company Limited

Financial Highlights

	FY 2009 (April 2009 - March 2010)	FY 2008 (April 2008 - March 2009)
Net Sales	¥1,466 billion (US$15,763 million)	¥1,538.3 billion (US$15,697 million)
Net Income	¥297.7 billion (US$3,202 million)	¥234.4 billion (US$2,392 million)
R&D Investment	¥296.4billion (US$3,187 million)	¥453.0billion (US$4,623 million)
Earnings Per Share	¥377.19 (US$4.06)	¥289.82 (US$2.96)
Dividends Per Share	¥180.00 (US$1.94)	¥180.00 (US$1.94)
Consolidated Subsidiaries	55 companies	49 companies
Affiliated Companies Accounted for by the Equity Method	15 companies	15 companies

[*]Note: The U.S. dollar amounts represent translations of Japanese yen, for convenience only, at the rate of ¥98=US$1 for FY 2008 and ¥100=US$1 for FY 2007.